| MRI | Magnetic Resonance Imaging |
| PET | Positron Emission Tomography |
| HIF | Hypoxia-Inducible Factor |
| VHL | Von Hippel–Lindau |
| IHC | Immunohistochemical |
| IF | Immunofluorescent |
| GLUT-1 | Glucose Transporter 1 |
| MCT-1 | Monocarboxylate Transporter 1 |
| CA-IX | Carbonic Anhydrase IX |
| NITP | A2-Nitroimidazole |
| PO2 | O2 Partial Pressure |
| PLIM | Phosphorescence Lifetime Imaging |
| HRE | Hypoxia-Responsive Element |
| ODD | Oxygen-Dependent Degradation |
| NTR | Nitroreductase |
| NIR | Near-Infrared |
| BLI | Bioluminescent Imaging |
| PAI | Photoacoustic Imaging |
| PA | Photoacoustic |
| AuNR | Gold Nanorod |
| CELI | Cherenkov-Excited Luminescence Imaging |
| BOLD | Blood-Oxygen-Level Dependent |
| TOLD | Tumor Oxygenation Level-Dependent |
| PISTOL | Proton Imaging of Siloxanes to map Tissue Oxygen Levels |
| MR-CA | Magnetic Resonance Contrast Amplification |
| EPRI | Electron Paramagnetic Resonance Imaging |
| 18F-FMISO | 18F-fluoromisonidazole |
| 18F-FAZA | 18F-fluoroazomycin arabinoside |
| fMRI | Functional Magnetic Resonance Imaging |